Patents Assigned to Life Sciences, Inc.
  • Patent number: 11162939
    Abstract: Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The assay comprises: combining a sample suspected of containing the analyte with the above-described composition and a binding agent that binds to the analyte; and detecting the signal or the first member of the second binding pair that is bound to the binding agent. In this assay, the amount of the signal or the first member of the second binding pair bound to the binding agent is inversely proportional to the analyte in the sample.
    Type: Grant
    Filed: March 9, 2020
    Date of Patent: November 2, 2021
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Jack Coleman, Maciej Szczepanik, Richard Jin
  • Patent number: 11162910
    Abstract: The present invention provides novel methods and devices that employ microfluidic technology to generate molecular melt curves. In particular, the devices and methods in accordance with the invention are useful in providing for the analysis of PCR amplification products.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: November 2, 2021
    Assignees: CALIPER LIFE SCIENCES, INC., Canon U.S.A., Inc.
    Inventors: Steven A. Sundberg, Michael R. Knapp, Ivor T. Knight, Deborah J. Boles, Aaron Rulison, Wesley B. Dong, Andrew Fabans, Edward Donlon, Robert Moti, Michael Slater
  • Publication number: 20210321873
    Abstract: A thermoacoustic transducer integrating at least one piezoelectric element having a first surface and a second surface, a potential electrode that is electrically connected to the second surface, a ground electrode that is electrically connected to the first surface, a switch electrically connected to both the potential electrode and the ground electrode, a timer configured to match a pulse emanating from a radio-frequency emitter, further wherein the potential electrode and the ground electrode are electrically connected through an impedance when the switch is in an active state, further wherein the potential electrode and the ground electrode are not electrically connected when the switch is in an inactive state; and a housing accommodating the at least one piezoelectric element, potential electrode, ground electrode, and switch.
    Type: Application
    Filed: April 14, 2021
    Publication date: October 21, 2021
    Applicant: ENDRA Life Sciences Inc.
    Inventors: Zackary Marc Mumm, Christopher Nelson Davis, Michael M. Thornton, Jang Hwan Cho
  • Publication number: 20210325375
    Abstract: Provided is a multisignal labeling reagent comprising a first polymer covalently bound to (a) a reactive group or a first member of a first binding pair, and (b) more than one digoxigenin molecule.
    Type: Application
    Filed: June 17, 2021
    Publication date: October 21, 2021
    Applicant: Enzo Life Science, Inc.
    Inventors: Jack Coleman, Maciej Szczepanik, Richard Jin
  • Patent number: 11141414
    Abstract: An oral pharmaceutical composition in unit dosage form comprising: (1) a first portion comprising: an active ingredient and a pH-dependent component, and (2) a second portion comprising a pH-raising agent is provided. Methods of administering the composition are also provided.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: October 12, 2021
    Assignee: Ohemo Life Sciences, Inc.
    Inventors: Manish S. Shah, Ray J. DiFalco
  • Patent number: 11141067
    Abstract: A thermoacoustic imaging system and method for monitoring tissue temperature within a region of interest, which has an object of interest and a reference that are separated by at least one boundary. The system and method include a thermoacoustic imaging system with an adjustable radio frequency (RF) applicator configured to emit RF energy pulses into the tissue region of interest and heat tissue therein, an acoustic receiver configured to receive bipolar acoustic signals generated in response to heating of tissue in the region of interest, and one or more processors that process at least one received bipolar acoustic signal generated in the region of interest in response to the RF energy pulses to determine a peak-to-peak amplitude thereof and calculate a temperature at the at least one boundary using the peak-to-peak amplitude of the at least one bipolar acoustic signal.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: October 12, 2021
    Assignee: ENDRA Life Sciences Inc.
    Inventors: Jang Hwan Cho, Paul A. Picot, Michael M. Thornton
  • Patent number: 11139050
    Abstract: Provided are systems and methods for pre-qualification of candidate patient populations. The systems and methods can be are configured for inexpensive, selective, and lightweight procedures that identify patients against desired criteria. In some implementations, willing participants are enrolled in pre-treatment execution of a clinical trial. The participants are issued telemedicine monitoring devices for capturing and reporting health information. For example, non-invasive monitoring devices can be issued to track mobility, exertion, blood pressure, heart rate, brain activity, among other options. The participants can be monitored for time periods similar to actual trial execution phases (e.g., monitoring periods of years can be used) or monitored for any length of time to develop comparable clinical histories for the participants.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: October 5, 2021
    Assignee: Transparency Life Sciences, Inc.
    Inventor: Bernard Munos
  • Publication number: 20210302445
    Abstract: Provided is an antibody composition comprising antibodies that specifically bind to 22-hydroxycholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 26-hydroxycholesterol or 27-hydroxycholesterol. Also provided is a method of making antibodies that specifically bind to 22-hydroxycholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 26-hydroxycholesterol or 27-hydroxycholesterol is provided. Further provided is a method of assaying for 22-hydroxycholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 26-hydroxycholesterol or 27-hydroxycholesterol is provided. Still further provided is a kit for detecting 22-hydroxycholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 26-hydroxycholesterol or 27-hydroxycholesterol.
    Type: Application
    Filed: April 14, 2021
    Publication date: September 30, 2021
    Applicant: ENZO LIFE SCIENCES, INC.
    Inventors: Michael C. Mullenix, ROBERT ELLIOT ZIPKIN, JEFFREY KROLL ADAMS, WAYNE FORREST PATTON, JAMES J. DONEGAN
  • Patent number: 11111546
    Abstract: A method is provided for detecting a cancer in an individual, the method comprising detection of a deletion in the nucleic acid sequence between residues 10743 and 14125 in mitochondrial DNA by extracting the mitochondrial DNA (mtDNA) from the biological sample obtained from the individual and quantifying the amount of mtDNA in the sample having a deletion in the nucleic acid sequence between approximately residues 10743 and 14125 of the mtDNA genome, and comparing the amount of mtDNA in the sample having the deletion to at least one known reference sample. Kits for conducting the method are also provided.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: September 7, 2021
    Assignee: MDNA Life Sciences, Inc.
    Inventors: Ryan L. Parr, Robert Thayer, Gabriel D. Dakubo, Jennifer Creed, Kerry Robinson, Andrea Maggrah, Brian Reguly
  • Publication number: 20210260144
    Abstract: The invention provides methods and compositions for assaying infectivity of viruses and potential treatments of such viruses in the upper respiratory tract using an air-liquid interface model with nasal epithelium cells; and treatment of viral infections of the upper respiratory tract by treating with bitter taste receptor agonists that stimulate NO production and/or antimicrobial protein production.
    Type: Application
    Filed: April 21, 2021
    Publication date: August 26, 2021
    Applicants: The Trustees of the University of Pennsylvania, Monell Chemical Senses Center, GeneOne Life Science, Inc.
    Inventors: Noam A. Cohen, Robert J. Lee, Susan R. Weiss, Joel N. Maslow, Christine C. Roberts, Sara Cherry, Michael Kohanski, Nithin D. Adappa, James N. Palmer, Li Hui Tan
  • Publication number: 20210244384
    Abstract: A method and system for optimizing RF energy delivery to a tissue ROI with a thermoacoustic system includes directing with a RF applicator, RF energy pulses into the tissue ROI having an object of interest and a reference separated by a boundary; detecting with a thermoacoustic transducer, a multi-polar thermoacoustic signal generated at the boundary in response to the RF energy pulses and processing the multi-polar acoustic signal to determine a peak-to-peak amplitude; detecting with the thermoacoustic transducer, an artifact multi-polar thermoacoustic signal generated at a location other than the boundary and processing it to determine a peak-to-peak amplitude; utilizing an electromagnetic model coupled with a model of patient anatomy to place dielectric or conducting materials near the thermoacoustic transducer or the RF applicator to optimize a signal-to-noise ratio of the multi-polar thermoacoustic signal generated at the boundary or minimize the artifact multi-polar thermoacoustic signal generated at a
    Type: Application
    Filed: February 12, 2020
    Publication date: August 12, 2021
    Applicant: ENDRA Life Sciences Inc.
    Inventors: Amanda Margaret Barnes, Christopher Nelson Davis, Michael M. Thornton
  • Patent number: 11083716
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: August 10, 2021
    Assignee: Achieve Life Sciences, Inc.
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • Patent number: 11083715
    Abstract: Methods of treatment of addiction and/or dependence, methods of promoting cessation of various addictions, such as smoking and/or vaping, and methods of promoting a reduction in various addictions, such as smoking and/or vaping, uses of cytisine as an addiction cessation treatment, and dosage regimens for the foregoing are provided.
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: August 10, 2021
    Assignee: Achieve Life Sciences, Inc.
    Inventors: Cindy A. Jacobs, Daniel F. Cain, Anthony Clarke
  • Patent number: 11077119
    Abstract: A method of treating a subject for a brain disease associated with cognitive impairment, including administering to a subject a chemical substance according to GLN-1062 or salt thereof: wherein the treatment includes transmucosal administration of a therapeutically effective amount of GLN 1062 or salt thereof in the oral cavity of the subject.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: August 3, 2021
    Assignee: Neurodyn Life Sciences Inc.
    Inventor: Alfred Maelicke
  • Patent number: 11073512
    Abstract: Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The assay comprises: combining a sample suspected of containing the analyte with the above-described composition and a binding agent that binds to the analyte; and detecting the signal or the first member of the second binding pair that is bound to the binding agent. Additionally provided is a multisignal labeling reagent comprising a first polymer covalently bound to (a) a reactive group or a first member of a first binding pair, and (b) more than one digoxigenin molecule.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: July 27, 2021
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Jack Coleman, Maciej Szczepanik, Richard Jin
  • Patent number: 11067543
    Abstract: A method for determining a parameter of a material of interest which includes: directing, using a radio frequency (RF) source, RF energy into a region of interest, the region of interest comprising the material, a known reference and a boundary between the material and the known reference; detecting, using an acoustic receiver, at least one thermoacoustic multi-polar signal generated in response to the RF energy; and determining, by the one or more processors, a parameter of the material as a function of the at least one thermoacoustic multi-polar signal and a transmitted power correction factor, wherein the transmitted power correction factor is based on an estimated thickness of the known reference and an attenuation coefficient of the known reference.
    Type: Grant
    Filed: October 3, 2019
    Date of Patent: July 20, 2021
    Assignee: ENDRA Life Sciences Inc.
    Inventor: Jang Hwan Cho
  • Patent number: 11051883
    Abstract: A system for thermal ablation of tissue and temperature monitoring of said tissue is disclosed. They system includes an insertion device configured to be inserted into said tissue, a radio-frequency source configured to transmit radio-frequency energy into said tissue via the insertion device, a pulse generator configured to pulse the radio-frequency source at a pre-determined pulse rate and generate a thermoacoustic signal in said tissue, a thermoacoustic transducer configured to receive the thermoacoustic signal, and a processor configured to utilize the thermoacoustic signal to calculate a temperature of said tissue.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: July 6, 2021
    Assignee: ENDRA Life Sciences Inc.
    Inventor: Michael M. Thornton
  • Patent number: 11051699
    Abstract: A method and system for estimating fractional fat content of an object of interest. The method and system include a thermoacoustic imaging system comprising an adjustable radio frequency (RF) applicator configured to emit RF energy pulses into the region of interest and heat tissue therein and an acoustic receiver configured to receive bipolar acoustic signals generated in response to heating of tissue in the region of interest; and one or more processors. The one or more processors are able to process bipolar acoustic signals received by the acoustic receiver in response to RF energy pulses emitted into the region of interest using the RF applicator to determine a setting for the RF applicator that yields bipolar acoustic signals with at least one enhanced metric thereof, determine an impedance of the RF applicator used to yield acoustic bipolar signals with the enhanced at least one metric, and estimate fractional fat content of the object of interest using the determined impedance.
    Type: Grant
    Filed: December 24, 2018
    Date of Patent: July 6, 2021
    Assignee: ENDRA Life Sciences Inc.
    Inventors: Christopher Nelson Davis, Jang Hwan Cho, Michael M. Thornton
  • Patent number: 11045422
    Abstract: An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprises a drug that is substantially homogeneously distributed within the second polymer and diffuses from the diffusion layer within the gastrointestinal (GI) tract; and optionally an expansion layer comprising an expandable polymer, wherein the expansion layer is substantially covered by the barrier layer. Methods of making the same and methods of using the same are also provided.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: June 29, 2021
    Assignee: OHENO LIFE SCIENCES, INC.
    Inventors: Manish S. Shah, Ray Difalco
  • Patent number: 11047832
    Abstract: A method for determining at least one parameter of interest of a material comprises directing, using a radio frequency (RF) applicator, one or more RF energy pulses into a region of interest, the region of interest comprising a material having a parameter of interest and at least one reference, the material and the reference separated by at least one boundary; detecting, using an acoustic receiver, at least one multi-polar acoustic signal generated in the region of interest in response to the RF energy pulses; processing the at least one multi-polar acoustic signal to determine an electric field strength at the boundary; calculating a voltage standing wave ratio (VSWR) of the one or more RF energy pulses; and determining the at least one parameter of interest of the material based at least on the determined electric field strength and the VSWR.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: June 29, 2021
    Assignee: ENDRA Life Sciences Inc.
    Inventor: Jang Hwan Cho